AT Impf
Europe, Bayern, Germany, Munich
Description
AT Impf was added in 2010.
Investor Profile
AT Impf has backed more than 6 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series D, Post Ipo Equity, Series C rounds (top funding stages).
- Majority of deals are located in Germany.
- Strong thematic focus on Biotechnology, Medical, Therapeutics.
Stage Focus
- Series D (33%)
- Post Ipo Equity (17%)
- Series C (17%)
- Series E (17%)
- Series Unknown (17%)
Country Focus
- Germany (100%)
Industry Focus
- Biotechnology
- Medical
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
